|
1
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol
Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Su Z, Yang Z, Xu Y, Chen Y and Yu Q:
MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget.
6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Degterev A, Huang Z, Boyce M, Li Y, Jagtap
P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J:
Chemical inhibitor of nonapoptotic cell death with therapeutic
potential for ischemic brain injury. Nat Chem Biol. 1:112–119.
2005. View Article : Google Scholar
|
|
4
|
Nikoletopoulou V, Markaki M, Palikaras K
and Tavernarakis N: Crosstalk between apoptosis, necrosis and
autophagy. Biochim Biophys Acta. 1833:3448–3459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schweichel JU and Merker HJ: The
morphology of various types of cell death in prenatal tissues.
Teratology. 7:253–266. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Leist M and Jäättelä M: Four deaths and a
funeral: From caspases to alternative mechanisms. Nat Rev Mol Cell
Biol. 2:589–598. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuksel S, Tosun YB, Cahill J and Solaroglu
I: Early brain injury following aneurysmal subarachnoid hemorrhage:
Emphasis on cellular apoptosis. Turk Neurosurg. 22:529–533.
2012.PubMed/NCBI
|
|
8
|
Green DR: Apoptotic pathways: Ten minutes
to dead. Cell. 121:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adams JM: Ways of dying: Multiple pathways
to apoptosis. Genes Dev. 17:2481–2495. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kroemer G, Galluzzi L and Brenner C:
Mitochondrial membrane permeabilization in cell death. Physiol Rev.
87:99–163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lévy J and Romagnolo B: Autophagy,
microbiota and intestinal oncogenesis. Oncotarget. 6:34067–34068.
2015.PubMed/NCBI
|
|
12
|
Ding WX, Ni HM, Gao W, Hou YF, Melan MA,
Chen X, Stolz DB, Shao ZM and Yin XM: Differential effects of
endoplasmic reticulum stress-induced autophagy on cell survival. J
Biol Chem. 282:4702–4710. 2007. View Article : Google Scholar
|
|
13
|
Galluzzi L and Kroemer G: Necroptosis: A
specialized pathway of programmed necrosis. Cell. 135:1161–1163.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Degterev A, Hitomi J, Germscheid M, Ch'en
IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, et al:
Identification of RIP1 kinase as a specific cellular target of
necrostatins. Nat Chem Biol. 4:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
You Z, Savitz SI, Yang J, Degterev A, Yuan
J, Cuny GD, Moskowitz MA and Whalen MJ: Necrostatin-1 reduces
histopathology and improves functional outcome after controlled
cortical impact in mice. J Cereb Blood Flow Metab. 28:1564–1573.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Degterev A, Zhou W, Maki JL and Yuan J:
Assays for necroptosis and activity of RIP kinases. Methods
Enzymol. 545:1–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang DW, Shao J, Lin J, Zhang N, Lu BJ,
Lin SC, Dong MQ and Han J: RIP3, an energy metabolism regulator
that switches TNF-induced cell death from apoptosis to necrosis.
Science. 325:332–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho YS, Challa S, Moquin D, Genga R, Ray
TD, Guildford M and Chan FK: Phosphorylation-driven assembly of the
RIP1-RIP3 complex regulates programmed necrosis and virus-induced
inflammation. Cell. 137:1112–1123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aggarwal BB: Signalling pathways of the
TNF superfamily: A double-edged sword. Nat Rev Immunol. 3:745–756.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Orrenius S: Reactive oxygen species in
mitochondria-mediated cell death. Drug Metab Rev. 39:443–455. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Z and El-Deiry WS: Distinct signaling
pathways in TRAIL-versus tumor necrosis factor-induced apoptosis.
Mol Cell Biol. 26:8136–8148. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vanden Berghe T, Declercq W and
Vandenabeele P: NADPH oxidases: New players in TNF-induced necrotic
cell death. Mol Cell. 26:769–771. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X and
Shen HM: zVAD-induced necroptosis in L929 cells depends on
autocrine production of TNFα mediated by the PKC-MAPKs-AP-1
pathway. Cell Death Differ. 18:26–37. 2011. View Article : Google Scholar
|
|
24
|
Micheau O and Tschopp J: Induction of TNF
receptor I-mediated apoptosis via two sequential signaling
complexes. Cell. 114:181–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ea CK, Deng L, Xia ZP, Pineda G and Chen
ZJ: Activation of IKK by TNFalpha requires site-specific
ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell.
22:245–257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vandenabeele P, Galluzzi L, Vanden Berghe
T and Kroemer G: Molecular mechanisms of necroptosis: An ordered
cellular explosion. Nat Rev Mol Cell Biol. 11:700–714. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Feng S, Yang Y, Mei Y, Ma L, Zhu DE, Hoti
N, Castanares M and Wu M: Cleavage of RIP3 inactivates its
caspase-independent apoptosis pathway by removal of kinase domain.
Cell Signal. 19:2056–2067. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He S, Wang L, Miao L, Wang T, Du F, Zhao L
and Wang X: Receptor interacting protein kinase-3 determines
cellular necrotic response to TNF-alpha. Cell. 137:1100–1111. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deutsch M, Graffeo CS, Rokosh R, Pansari
M, Ochi A, Levie EM, Van Heerden E, Tippens DM, Greco S, Barilla R,
et al: Divergent effects of RIP1 or RIP3 blockade in murine models
of acute liver injury. Cell Death Dis. 6:e17592015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Irrinki KM, Mallilankaraman K, Thapa RJ,
Chandramoorthy HC, Smith FJ, Jog NR, Gandhirajan RK, Kelsen SG,
Houser SR, May MJ, et al: Requirement of FADD, NEMO, and BAX/BAK
for aberrant mitochondrial function in tumor necrosis factor
alpha-induced necrosis. Mol Cell Biol. 31:3745–3758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun L, Wang H, Wang Z, He S, Chen S, Liao
D, Wang L, Yan J, Liu W, Lei X, et al: Mixed lineage kinase
domain-like protein mediates necrosis signaling downstream of RIP3
kinase. Cell. 148:213–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iadecola C and Anrather J: The immunology
of stroke: From mechanisms to translation. Nat Med. 17:796–808.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Engelhardt B and Sorokin L: The
blood-brain and the blood-cerebrospinal fluid barriers: Function
and dysfunction. Semin Immunopathol. 31:497–511. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Konsman JP, Drukarch B and Van Dam AM:
(Peri)vascular production and action of pro-inflammatory cytokines
in brain pathology. Clin Sci (Lond). 112:1–25. 2007. View Article : Google Scholar
|
|
35
|
Jung KH, Yu KH, Kim YD, Park JM, Hong KS,
Rha JH, Kwon SU, Bae HJ, Heo JH, Lee BC, et al: Antithrombotic
management of patients with nonvalvular atrial fibrillation and
ischemic stroke or transient ischemic attack: Executive summary of
the Korean Clinical Practice Guidelines for Stroke. J Stroke.
17:210–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Yang W, Xie H, Song Y, Li Y and
Wang L: Ischemic stroke and repair: current trends in research and
tissue engineering treatments. Regen Med Res. 2:32014. View Article : Google Scholar
|
|
37
|
Oerlemans MI, Liu J, Arslan F, den Ouden
K, van Middelaar BJ, Doevendans PA and Sluijter JP: Inhibition of
RIP1-dependent necrosis prevents adverse cardiac remodeling after
myocardial ischemia-reperfusion in vivo. Basic Res Cardiol.
107:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rosenbaum DM, Degterev A, David J,
Rosenbaum PS, Roth S, Grotta JC, Cuny GD, Yuan J and Savitz SI:
Necroptosis, a novel form of caspase-independent cell death,
contributes to neuronal damage in a retinal ischemia-reperfusion
injury model. J Neurosci Res. 88:1569–1576. 2010.
|
|
39
|
Linkermann A, Bräsen JH, Himmerkus N, Liu
S, Huber TB, Kunzendorf U and Krautwald S: Rip1
(receptor-interacting protein kinase 1) mediates necroptosis and
contributes to renal ischemia/reperfusion injury. Kidney Int.
81:751–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zheng W, Degterev A, Hsu E, Yuan J and
Yuan C: Structure-activity relationship study of a novel
necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett.
18:4932–4935. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Beal MF: Role of excitotoxicity in human
neurological disease. Curr Opin Neurobiol. 2:657–662. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tabrizi SJ, Cleeter MW, Xuereb J, Taanman
JW, Cooper JM and Schapira AH: Biochemical abnormalities and
excitotoxicity in Huntington's disease brain. Ann Neurol. 45:25–32.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Beal MF: Excitotoxicity and nitric oxide
in Parkinson's disease pathogenesis. Ann Neurol. 44(Suppl 1):
S110–S114. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonde C, Noraberg J, Noer H and Zimmer J:
Ionotropic glutamate receptors and glutamate transporters are
involved in necrotic neuronal cell death induced by oxygen-glucose
deprivation of hippocampal slice cultures. Neuroscience.
136:779–794. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Günther C, Martini E, Wittkopf N, Amann K,
Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath
MF, et al: Caspase-8 regulates TNF-α-induced epithelial necroptosis
and terminal ileitis. Nature. 477:335–339. 2011. View Article : Google Scholar
|
|
46
|
Fulda S: The mechanism of necroptosis in
normal and cancer cells. Cancer Biol Ther. 14:999–1004. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu P, Xu B, Shen W, Zhu H, Wu W, Fu Y,
Chen H, Dong H, Zhu Y, Miao K, et al: Dysregulation of TNFα-induced
necroptotic signaling in chronic lymphocytic leukemia: Suppression
of CYLD gene by LEF1. Leukemia. 26:1293–1300. 2012. View Article : Google Scholar
|
|
48
|
Cerhan JR, Ansell SM, Fredericksen ZS, Kay
NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares
W, et al: Genetic variation in 1253 immune and inflammation genes
and risk of non-Hodgkin lymphoma. Blood. 110:4455–4463. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo
J and Hu X: Shikonin circumvents cancer drug resistance by
induction of a necroptotic death. Mol Cancer Ther. 6:1641–1649.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wada N, Kawano Y, Fujiwara S, Kikukawa Y,
Okuno Y, Tasaki M, Ueda M, Ando Y, Yoshinaga K, Ri M, et al:
Shikonin, dually functions as a proteasome inhibitor and a
necroptosis inducer in multiple myeloma cells. Int J oncol.
46:963–972. 2015. View Article : Google Scholar :
|
|
51
|
Fu Z, Deng B, Liao Y, Shan L, Yin F, Wang
Z, Zeng H, Zuo D, Hua Y and Cai Z: The anti-tumor effect of
shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent
necroptosis. BMC Cancer. 13:5802013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xuan Y and Hu X: Naturally-occurring
shikonin analogues - a class of necroptotic inducers that
circumvent cancer drug resistance. Cancer Lett. 274:233–242. 2009.
View Article : Google Scholar
|
|
53
|
Smith CC, Davidson SM, Lim SY, Simpkin JC,
Hothersall JS and Yellon DM: Necrostatin: A potentially novel
cardioprotective agent? Cardiovasc Drugs Ther. 21:227–233. 2007.
View Article : Google Scholar : PubMed/NCBI
|
